Aditxt Inc

NASDAQ:ADTX 4:00:00 PM EDT

2.27

+0.05 (+2.25%)

5:48:30 PM EDT: $2.33 +0.06 (+2.64%)

Market Cap (Intraday)	4.45M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.31 Million
Adjusted EPS	-$4.40

See more estimates

10-Day MA	$2.54
50-Day MA	$3.29
200-Day MA	$8.65

See more pivots

Aditxt Inc Stock, NASDAQ:ADTX

737 North Fifth Street, Suite 200, Richmond, Virginia 23219

United States of America

Phone: +1.650.870.1200

Number of Employees: 47

http://www.aditxt.com

Description

Aditxt, Inc. is a biotech innovation company, which engages in the development and commercialization of technologies focusing on monitoring and modulating the immune system. Its innovation portfolio includes Adimune and AditxtScore. The company was founded by Leonard L. Bailey, Shahrokh Shabahang, and Amro Albanna on September 28, 2017 and is headquartered in Richmond, VA.